09-19-2019, 07:05 AM
My experience with T@p is under an incredible amount of scrutiny/scarcity because it’s not only s2, but relatively new, and thus for some reason harder to get prescribed than MS, Ox, etc. (which are FAR more effective meds imo). T@p is structurally similar to Tr@m, sorta like its older brother. They both have quite a weak effect on me, yet are guarded and considered as strong by many docs as MS/Cod respectively.
Have seen the hoops relatives have had to jump through just to have the chance to TRY it, only to realize to their horror that they’re stuck with a months supply of it in lieu of something that was helping them much more. In general the atypical side effect profile (potential for seizures either upon use or withdrawal), weak efficacy, and incredibly scrutiny/low rates of prescription make it a pretty undesirable choice all the way around. Of those I know personally, all more or less agree.
Have seen the hoops relatives have had to jump through just to have the chance to TRY it, only to realize to their horror that they’re stuck with a months supply of it in lieu of something that was helping them much more. In general the atypical side effect profile (potential for seizures either upon use or withdrawal), weak efficacy, and incredibly scrutiny/low rates of prescription make it a pretty undesirable choice all the way around. Of those I know personally, all more or less agree.